Related Experiment Video
Updated: Aug 10, 2026
12:45
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
6.8K
[Robot-assisted cystprostatectomy for urinary bladder cancer (the first experience)]
S V Yarmoshchuk1, A S Kudryavtsev1, A A Zeravin1
1Academician E.N. Meshalkin Novosibirsk State Research Institute of Circulation Pathology.
Urologiia (Moscow, Russia : 1999)
|March 2, 2017
Summary
Robot-assisted radical cystprostatectomy with intracorporeal ileal neobladder reconstruction was successfully performed in a young patient with advanced bladder cancer. The procedure demonstrated minimal blood loss and no complications, with prompt restoration of voiding function.
Area of Science:
- Urology
- Surgical Oncology
- Robotic Surgery
Background:
- Robot-assisted radical cystprostatectomy (RARC) is an evolving treatment for bladder cancer.
- Intracorporeal ileal neobladder (ICNB) creation is a complex reconstructive technique.
- This case explores the feasibility of RARC with ICNB in a young patient with extensive disease.
Observation:
- A 36-year-old male presented with highly differentiated infiltrative urothelial bladder cancer, Gr 2, multicentric, invading the bladder wall, urethral mucosa, and prostate.
- The patient underwent a 6-hour robot-assisted radical cystprostatectomy with intracorporeal ileal neobladder construction.
- Intraoperative blood loss was 150 ml, with no intra- or postoperative complications observed.
Findings:
- Successful completion of RARC and ICNB in a single procedure.
- No adverse events or complications during or after surgery.
- Restoration of spontaneous voiding by postoperative day 10.
Implications:
- This case highlights the potential of minimally invasive robotic surgery for complex urological reconstructions in young patients with urothelial carcinoma.
- RARC with ICNB may offer a viable alternative to open surgery, potentially leading to faster recovery and improved functional outcomes.
- Further research is warranted to evaluate long-term oncological and functional results in a larger patient cohort.
